Drug intelligence / Profile preview

CARBOXY-DS

Development stage: Unknown
Lead developer: Protech Remedies
Modality: Small Molecules
Administration: Ophthalmic

Overview

CARBOXY-DS is a topical ophthalmic lubricant developed by Protech Remedies for the treatment of dry eye syndrome. Its active ingredient is carboxymethylcellulose (sodium carboxymethylcellulose), a cellulose derivative that acts as an artificial tear substitute. The formulation is designed to mimic natural tears, providing temporary relief from burning, irritation, and discomfort by increasing tear film stability and forming a protective film over the ocular surface. It is a "Bak Free" formulation, utilizing Oxychloro Complex as a preservative to minimize ocular surface toxicity and maintain proper eye lubrication.

Brand names: CARBOXY-DSCarboxy DS Eye Drop Bak Free
Other names: CARBOXY-DS Eye Drops

Targets

MUC5AC (Mucin-5AC)GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on CARBOXY-DS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CARBOXY-DS.

Explore the full profile